Effects of imatinib mesylate on cutaneous neurofibromas associated with neurofibromatosis type 1.

Imatinib mesylate seemed to inhibit development of cutaneous neurofibromas (c-NFs) and promote growth of pre-existing c-NFs in our neurofibromatosis type 1 case. This report potentially provides new findings in the effects of imatinib mesylate.